JP2024537906A5 - - Google Patents

Info

Publication number
JP2024537906A5
JP2024537906A5 JP2024523414A JP2024523414A JP2024537906A5 JP 2024537906 A5 JP2024537906 A5 JP 2024537906A5 JP 2024523414 A JP2024523414 A JP 2024523414A JP 2024523414 A JP2024523414 A JP 2024523414A JP 2024537906 A5 JP2024537906 A5 JP 2024537906A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
mucositis
effective amount
susceptible
human subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537906A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/060007 external-priority patent/WO2023067501A1/en
Publication of JP2024537906A publication Critical patent/JP2024537906A/ja
Publication of JP2024537906A5 publication Critical patent/JP2024537906A5/ja
Pending legal-status Critical Current

Links

JP2024523414A 2021-10-18 2022-10-18 粘膜炎を処置するための組成物及び方法 Pending JP2024537906A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163257099P 2021-10-18 2021-10-18
US63/257,099 2021-10-18
PCT/IB2022/060007 WO2023067501A1 (en) 2021-10-18 2022-10-18 Compositions and methods for treating mucositis

Publications (2)

Publication Number Publication Date
JP2024537906A JP2024537906A (ja) 2024-10-16
JP2024537906A5 true JP2024537906A5 (https=) 2025-10-27

Family

ID=86057963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523414A Pending JP2024537906A (ja) 2021-10-18 2022-10-18 粘膜炎を処置するための組成物及び方法

Country Status (5)

Country Link
US (1) US20240415798A1 (https=)
EP (1) EP4419096A4 (https=)
JP (1) JP2024537906A (https=)
KR (1) KR20240089762A (https=)
WO (1) WO2023067501A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5026655B2 (ja) * 2001-04-18 2012-09-12 プロメティック、バイオサイエンシーズ、インコーポレーテッド 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
IL274974B2 (en) * 2017-11-30 2025-03-01 Enzychem Lifesciences Corp Compositions for prevention or treatment of acute radiation syndrome

Similar Documents

Publication Publication Date Title
Rasmussen et al. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis
JP6353577B2 (ja) 組み合わせ組成物
WO2022218958A1 (en) Combination comprising everolimus and amcenestrant
AU2019328903B2 (en) Composition for eradicating Helicobacter pylori
JP2016531949A (ja) モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療
EP2723448B1 (en) Compositions for the treatment of chronic fatigue
CN103533940A (zh) 治疗晚期实体瘤的方法
JP2010505854A (ja) 低投与量のスタンソポルフィンを用いる幼児の高ビリルビン血症の治療
JP2023548429A5 (https=)
JP2023522415A5 (https=)
JP2024537906A5 (https=)
WO2021023291A1 (zh) 原黄素在肺癌治疗中的应用
CN103596565B (zh) 塞克硝唑在口腔感染治疗中的应用
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
JP2012031141A (ja) 骨髄異形性症候群を治療するための組成物および方法
TW202317084A (zh) 新穎治療
JP2024531799A5 (https=)
JP2022546042A5 (https=)
Andriiaka et al. OPTIMIZATION OF DIAGNOSIS OF SECONDARY METABOLIC DISORDERS AND TREATMENT TACTICS IN PATIENTS WITH ANEMIA IN NEOPLASTIC DISEASE IN COLORECTAL CANCER
US9913816B2 (en) Method for applying metformin and sodium butyrate in K-ras mutation cancer treatment
WO2019128511A1 (zh) 片仔癀及其制剂在制备治疗带状疱疹后遗神经痛的药物中的用途
Das et al. A brief review of muco-protective agent in the treatment of recurrent aphthous ulcer and behcet’s syndrome: Rebamipide
CN110891574A (zh) 用于预防和/或治疗肝细胞癌的美格列明
WO2025103426A1 (zh) 白塞综合征的治疗
TW202612698A (zh) 吞噬血球症候群治療劑及其用途